Contact
searchSearch
HMP Global
Podcasts

Dr Brodell on Providing Dermatologic Care in Rural Communities

Robert T. Brodell, MD
08/04/2021

In this first episode of The Derm Editor's Corner, Dr Robert Brodell shares his insights improving access to care in rural America, including tips for using teledermatology.

Recent Highlights

alopecia areata
Conference Coverage
JAK Inhibitors in Alopecia Areata: Long-Term Success, Individualized Strategy, and the Emerging Role of Eyebrow Outcomes
11/26/2025
Jessica Garlewicz
Through patient cases and data review, the presenters emphasized the need to think beyond the scalp, personalize treatment duration and dosing, and recognize the growing significance of eyebrow regrowth as a marker of patient satisfaction.
Through patient cases and data review, the presenters emphasized the need to think beyond the scalp, personalize treatment duration and dosing, and recognize the growing significance of eyebrow regrowth as a marker of patient satisfaction.
Through patient cases and data...
11/26/2025
The Dermatologist
atopic dermatitis
Conference Coverage
Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application
11/26/2025
Jessica Garlewicz
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized...
11/26/2025
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
Charting a Path to Higher Treatment Targets With JAK Inhibition in Atopic Dermatitis
11/01/2025
Jessica Garlewicz
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating...
11/01/2025
The Dermatologist
Natasha Atanaskova-Mesinkovska, MD, PhD
Conference Coverage
JAK Inhibitors for Alopecia Areata: Clinical Insights and Emerging Strategies
10/28/2025
Jessica Garlewicz
At Fall Clinical 2025, Natasha Atanaskova-Mesinkovska, MD, PhD, presented a candid and case-based review of current treatment strategies for alopecia areata.
At Fall Clinical 2025, Natasha Atanaskova-Mesinkovska, MD, PhD, presented a candid and case-based review of current treatment strategies for alopecia areata.
At Fall Clinical 2025, Natasha...
10/28/2025
The Dermatologist
acne
Conference Coverage
Optimizing Acne Management With Durable Topical and Oral Therapies
10/28/2025
Jessica Garlewicz
At the Fall Clinical 2025 session, Mark Lebwohl, MD, reviewed recent data supporting the long-term efficacy of topical and oral therapies in acne management, focusing on durability, scarring, and sebum reduction.
At the Fall Clinical 2025 session, Mark Lebwohl, MD, reviewed recent data supporting the long-term efficacy of topical and oral therapies in acne management, focusing on durability, scarring, and sebum reduction.
At the Fall Clinical 2025...
10/28/2025
The Dermatologist
April W. Armstrong, MD
Conference Coverage
Rethinking the Role of Orals: Where TYK2 Inhibitors Fit in Psoriasis Management
10/27/2025
Jessica Garlewicz
The discussion centered on patient preferences, mechanism-driven selectivity, and a growing oral therapy pipeline that may shift long-standing practice paradigms.
The discussion centered on patient preferences, mechanism-driven selectivity, and a growing oral therapy pipeline that may shift long-standing practice paradigms.
The discussion centered on...
10/27/2025
The Dermatologist
Mittal Patel-Cohen
Conference Coverage
Hidradenitis Suppurativa: Phenotypes, Pitfalls, and Expanding Treatments
10/26/2025
Riya Gandhi, MA
Dr Patel-Cohen laid out diagnostic pearls, comorbidity considerations, and an expansive update on both conventional and emerging therapies of hidradenitis suppurativa.
Dr Patel-Cohen laid out diagnostic pearls, comorbidity considerations, and an expansive update on both conventional and emerging therapies of hidradenitis suppurativa.
Dr Patel-Cohen laid out...
10/26/2025
The Dermatologist
Brett King
Conference Coverage
Challenges and Treatments in Alopecia Areata
10/26/2025
Riya Gandhi, MA
At Dermatology Week 2025, Brett King, MD, PhD, presented an energizing overview of how far alopecia areata (AA) care has come, and where it is headed.
At Dermatology Week 2025, Brett King, MD, PhD, presented an energizing overview of how far alopecia areata (AA) care has come, and where it is headed.
At Dermatology Week 2025, Brett...
10/26/2025
The Dermatologist
Elizabeth (Lisa) A. Swanson, MD
Conference Coverage
Oral Therapies in Focus: Where Pills Fit in a Biologic-Dominated Psoriasis Landscape
10/24/2025
Jessica Garlewicz
This panel addressed emerging oral IL-23 inhibitors, the durability of current biologics, and patient preferences, framing the discussion around evolving treatment goals like on-treatment remission and real-world clinical needs.
This panel addressed emerging oral IL-23 inhibitors, the durability of current biologics, and patient preferences, framing the discussion around evolving treatment goals like on-treatment remission and real-world clinical needs.
This panel addressed emerging...
10/24/2025
The Dermatologist
psoriasis
Conference Coverage
Integrating GLP-1 Receptor Agonists in Psoriatic Disease: A Dual-Target Approach to Inflammation and Obesity
10/24/2025
Jessica Garlewicz
The discussion centered on the dual role of these agents in reducing systemic inflammation and promoting weight loss—2 factors strongly linked to psoriasis pathophysiology and therapeutic response.
The discussion centered on the dual role of these agents in reducing systemic inflammation and promoting weight loss—2 factors strongly linked to psoriasis pathophysiology and therapeutic response.
The discussion centered on the...
10/24/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use